Long-term Outcome of Splenectomy in Immune Thrombocytopenia (ITP)

Dutta, Tarun Kumar (2023) Long-term Outcome of Splenectomy in Immune Thrombocytopenia (ITP). Asian Hematology Research Journal, 7 (3). pp. 16-19.

[thumbnail of 30224-Article Text-56649-2-10-20230415.pdf] Text
30224-Article Text-56649-2-10-20230415.pdf - Published Version

Download (377kB)

Abstract

ITP is a chronic illness with frequent mucosal bleeding. Though the first line treatment is corticosteroids, relapse is frequent which necessitates splenectomy. Response to splenectomy is usually good initially; however, over the years relapses are frequent. Drugs then used are azathioprine, mycophenolate mofetil, anti-D globulin, TPO-receptor agonists, rituximab, cyclosporine, etc. Ultimately there is a small subset of patients who may require a small dose of prednisolone lifelong.

Item Type: Article
Subjects: Universal Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 17 Apr 2023 05:00
Last Modified: 09 Jan 2024 04:11
URI: http://journal.article2publish.com/id/eprint/1707

Actions (login required)

View Item
View Item